GLP-2 — TIRZ (Tirzepatide)

SKU: GLP-2-TIRZ   |   Category: GLP Series

Dual GIP/GLP-1 receptor co-agonist | Lyophilized | ≥99% purity

Tirzepatide is a 39-amino acid synthetic peptide engineered as a dual agonist at both GIP and GLP-1 receptors. Its structure incorporates a C20 fatty diacid moiety enabling strong albumin binding, prolonging pharmacokinetic half-life in vitro. Unlike monoagonist GLP-1 peptides, tirzepatide’s concurrent GIP receptor activation results in additive intracellular signaling profiles, as demonstrated in receptor activation assays and cAMP accumulation studies.

Research applications include receptor binding competition assays, dose-response modeling in pancreatic and adipose cell lines, comparative pharmacology studies versus GLP-1 monoagonists, and investigation of downstream metabolic gene expression. The compound’s well-characterized structure makes it a widely used reference standard in metabolic peptide research.

Manufactured in ISO 9001 certified, GMP-compliant facilities. Independently tested at ≥99% purity by HPLC via ISO/IEC 17025 accredited laboratory. Full COA available on the testing page.

Storage: Store lyophilized at -20°C. Reconstituted: 4°C, use within 28 days.

⚠ For laboratory research use only. Not for human or animal consumption.